Related Experiment Videos
[beta 2-Adrenomimetics before and after extracorporeal lithotripsy]
Urologiia I Nefrologiia
|November 20, 1998
Summary
Normalizing urinary tract dynamics with hexoprenalin (hinipral) aids kidney stone disintegration. This treatment improves fragment passage, preventing complications during extracorporeal shock-wave lithotripsy for nephrolithiasis.
Area of Science:
- Urology
- Pharmacology
Background:
- Nephrolithiasis (kidney stones) treatment requires normalized upper urinary tract urodynamics.
- Ureteropelvic dysfunction complicates calculus disintegration and extracorporeal shock-wave lithotripsy (ESWL).
Purpose of the Study:
- To evaluate the efficacy of combined treatment with hexoprenalin (hinipral) for nephrolithiasis patients.
- To assess hexoprenalin's role in improving stone fragment migration and preventing ESWL complications.
Main Methods:
- Combined treatment utilizing the beta-2-adrenomimetic hexoprenalin (hinipral).
- Administration of hexoprenalin orally (6 tablets/day) or intravenously (5 ml/100 ml saline) pre- and post-ESWL.
- Treatment duration: 3-5 days before and 10-12 days after ESWL.
Main Results:
- Hexoprenalin facilitates concrement fragment migration, preventing ureteral occlusion.
- Adjuvant hexoprenalin use prevents acute pyelonephritis and renal colic.
- Effective conduction of lithotripsy in nephrolithiasis complicated by ureteropelvic dysfunction.
Conclusions:
- Combined treatment with hexoprenalin is crucial for successful nephrolithiasis management.
- Hexoprenalin normalizes urodynamics, enhancing ESWL outcomes and patient recovery.
- This approach effectively manages kidney stones with associated urinary tract dysfunction.